MedTrace Logo

A Plaque Test Comparing the Anti-psoriatic Effect of Marketed Products for Topical Use for Psoriasis Vulgaris

NCT00845481 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2025-03-12

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to compare the anti-psoriatic effect of marketed products with Daivobet® ointment in a plaque test

Conditions

  • Psoriasis Vulgaris

Interventions

DRUG

Daivobet® ointment

Once daily application 6 days a week for 3 weeks

DRUG

Betnovat® ointment

Once daily application 6 days a week for 3 weeks

DRUG

Diprosalic ointment

Once daily application 6 days a week for 3 weeks

DRUG

Dermovat ointment

Once daily application 6 days a week for 3 weeks

DRUG

Elocon ointment

Once daily application 6 days a week for 3 weeks

DRUG

Daivobet® ointment vehicle

Once daily application 6 days a week for 3 weeks

Sponsors & Collaborators

  • LEO Pharma

    lead INDUSTRY

Principal Investigators

  • Medical Expert · LEO Pharma

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2009-03-31
Completion
2009-05-31

Countries

  • France

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00845481 on ClinicalTrials.gov